BioTrinity WelcomeStuart Rose, CEO
Keynote: A review of the life sciences investment landscape
Tim Haines
  • Tim Haines (Executive Partner at Abingworth)

    Tim Haines

    Executive Partner at Abingworth
Panel: An insider guide to Grant fundingwhat are your options and how to access it
Ana BarjasicIna KunzeEsther LawrenceEmma LonglandAndy RobertsSamana Brannigan
  • Ana Barjasic (CEO/Board Member of Connectology/European Innovation Council)

    Ana Barjasic

    CEO/Board Member of Connectology/European Innovation Council
  • Ina Kunze (BD&L Director Funding EU of Bayer AG)

    Ina Kunze

    BD&L Director Funding EU of Bayer AG
  • Esther Lawrence (Head of Business Development – Grants at TBAT Innovation)

    Esther Lawrence

    Head of Business Development – Grants at TBAT Innovation
  • Emma Longland (Patent Director, Patent Attorney of Venner Shipley)

    Emma Longland

    Patent Director, Patent Attorney of Venner Shipley
  • Andy Roberts (Head of Innovation - Life Sciences at Bruntwood SciTech)

    Andy Roberts

    Head of Innovation - Life Sciences at Bruntwood SciTech
  • Samana Brannigan (Innovation Lead at Innovate UK (UKRI))

    Samana Brannigan

    Innovation Lead at Innovate UK (UKRI)
Keynote: The benefits of London as a listing venue for your company
Tim Davies
  • Tim Davies (Regional Head, UK Primary Markets at London Stock Exchange)

    Tim Davies

    Regional Head, UK Primary Markets at London Stock Exchange
Networking Lunch
Keynote: Navigating Tax: the importance of early planning to survive fundraising, R&D and exits
Carole Le PageSteven Levine
  • Carole Le Page (Partner - Head of Life Sciences Tax at BDO)

    Carole Le Page

    Partner - Head of Life Sciences Tax at BDO
  • Steven Levine (Innovation Incentives Partner at BDO)

    Steven Levine

    Innovation Incentives Partner at BDO
Panel: Regulatory reviewa discussion on the latest regulatory updates impacting biotech and medtech SMEs, how to ensure compliance and overcome challenges
Chris CarrLisa PageCarole PughKirsty WydenbachJulian Beach
  • Chris Carr (Head of Regulatory Affairs at Cell and Gene Therapy Catapult)

    Chris Carr

    Head of Regulatory Affairs at Cell and Gene Therapy Catapult
  • Lisa Page (Partner at Penningtons Manches Cooper)

    Lisa Page

    Partner at Penningtons Manches Cooper
  • Carole Pugh (General Manager at QbD)

    Carole Pugh

    General Manager at QbD
  • Kirsty Wydenbach (Head of Regulatory Strategy and Drug Development Clinician at Weatherden)

    Kirsty Wydenbach

    Head of Regulatory Strategy and Drug Development Clinician at Weatherden
  • Julian Beach (Executive Director, Healthcare Quality and Access of MHRA)

    Julian Beach

    Executive Director, Healthcare Quality and Access of MHRA
Panel: Leading the Waywhat it's really like at the helm of one of the UK's leading life sciences R&D SMEs
Catherine BeechHannah SoreNeil TorbettClare Wareing
  • Catherine Beech (CEO of Exonate)

    Catherine Beech

    CEO of Exonate
  • Hannah Sore (Co-founder & CEO of PharmEnable Therapeutics)

    Hannah Sore

    Co-founder & CEO of PharmEnable Therapeutics
  • Neil Torbett (CEO of PhoreMost)

    Neil Torbett

    CEO of PhoreMost
  • Clare Wareing (Founder of Cumulus Oncology)

    Clare Wareing

    Founder of Cumulus Oncology
Panel: A discussion around the macro-environmental factors impacting life sciences R&D companies
Jordy BreukerPhilip CampbellGary Ford CBEEmma Palmer FosterSteve Silvey
  • Jordy Breuker (Associate Capital Advisory at F.INSTITUTE)

    Jordy Breuker

    Associate Capital Advisory at F.INSTITUTE
  • Philip Campbell (Commercial Director of MEPC Milton Park)

    Philip Campbell

    Commercial Director of MEPC Milton Park
  • Gary Ford CBE (CEO of Health Innovation Oxford & Thames Valley)

    Gary Ford CBE

    CEO of Health Innovation Oxford & Thames Valley
  • Emma Palmer Foster (Consultant at EJ Palmer Consulting)

    Emma Palmer Foster

    Consultant at EJ Palmer Consulting
  • Steve Silvey (Deputy Head of Licensing & Ventures – Life Sciences at Oxford University Innovation (OUI))

    Steve Silvey

    Deputy Head of Licensing & Ventures – Life Sciences at Oxford University Innovation (OUI)
Big Pharma Showcase: An insight into strategic disease focus, identifying targets early, and how biotech can build long term relationships with big pharma
Sue BaileyRebecca CanterMark DowlingChloé LeprêtreAndrew McConaghie
  • Sue Bailey (Senior Director, Geographic Search Europe of Bristol Myers Squibb)

    Sue Bailey

    Senior Director, Geographic Search Europe of Bristol Myers Squibb
  • Rebecca Canter (Senior Director of Lilly Ventures)

    Rebecca Canter

    Senior Director of Lilly Ventures
  • Mark Dowling (Head of Search & Evaluation for Immunology Business Development at Sanofi)

    Mark Dowling

    Head of Search & Evaluation for Immunology Business Development at Sanofi
  • Chloé Leprêtre (Global Head, R&D Search and Evaluation at Servier)

    Chloé Leprêtre

    Global Head, R&D Search and Evaluation at Servier
  • Andrew McConaghie (Senior Writer, Scrip at Citeline)

    Andrew McConaghie

    Senior Writer, Scrip at Citeline
Panel: An insight into the Inflation Reduction Act and implications on indication selection, clinical development strategy and M&A
Dean GriffithsDuncan McHalePremal PajwaniEmma TinsleyJames Fry
  • Dean Griffiths (Managing Director & London Office Head of Clearview Partners)

    Dean Griffiths

    Managing Director & London Office Head of Clearview Partners
  • Duncan McHale (Co-founder and Expert Drug Development Clinician of Weatherden)

    Duncan McHale

    Co-founder and Expert Drug Development Clinician of Weatherden
  • Premal Pajwani (Principal, Founder & CEO of PRP Advisory)

    Premal Pajwani

    Principal, Founder & CEO of PRP Advisory
  • Emma Tinsley (CEO of Weatherden)

    Emma Tinsley

    CEO of Weatherden
  • James Fry (Partner - Head of Life Sciences at Mills & Reeve)

    James Fry

    Partner - Head of Life Sciences at Mills & Reeve
Networking Lunch
Keynote: Cultivating entrepreneurship and Translation
Tony Hickson
  • Tony Hickson (Chief Business Officer at Cancer Research UK /Cancer Research Horizons)

    Tony Hickson

    Chief Business Officer at Cancer Research UK /Cancer Research Horizons
Panel: What does a good deal look like, and what investors (really) want
Maina BhamanGonzalo GarciaJan-Philipp KruseStephanie LeouzonDavid MottAllan Marchington
  • Maina Bhaman (Partner at Sofinnova Partners)

    Maina Bhaman

    Partner at Sofinnova Partners
  • Gonzalo Garcia (Investment Partner at Syncona)

    Gonzalo Garcia

    Investment Partner at Syncona
  • Jan-Philipp Kruse (Senior Director BD&L, Lead CoLab Berlin of Bayer AG)

    Jan-Philipp Kruse

    Senior Director BD&L, Lead CoLab Berlin of Bayer AG
  • Stephanie Leouzon (Managing Director, Biopharma, Healthcare of Stifel)

    Stephanie Leouzon

    Managing Director, Biopharma, Healthcare of Stifel
  • David Mott (Founder Partner of Oxford Capital)

    David Mott

    Founder Partner of Oxford Capital
  • Allan Marchington (Head of Life Sciences at ICG)

    Allan Marchington

    Head of Life Sciences at ICG

The BioTrinity programme is designed to be relevant, useful & thought-provoking and features three tracks over two-days, which includes:

  • Two Scientific Spotlight tracks, featuring update keynotes and showcase presentations from some of the most exciting R&D companies at series A stage across a range of therapy areas
  • A Business & Investment focused track, featuring keynotes and discussions addressing a broad range of hot topics currently impacting life sciences


CALL FOR SPEAKERS!

Email Jane O'Driscoll if you'd like to be considered for a speaking or presentation opportunity across any of the science or business sessions.  


Click here for a downloadable version of the BioTrinity programme